Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
Innovation and Product Development news
(page 20)
25 March 2026
Boehringer Ingelheim launches two late-stage medicines, 2025 sales up 7.3%
R&D spend rose to €6.4bn (22.9% of sales); reached 70M patients; Human Pharma and Animal Health grew—JARDIANCE and OFEV expanded; Animal Health up 6.5% with NEXGARD leading; pipeline >80 projects.
25 March 2026
Novo Nordisk: UBT251 reduced HbA1c up to 2.16% at 24 weeks in Chinese Phase 2 T2D trial
Triple-agonist UBT251 (GLP-1/GIP/glucagon) induced up to 9.8% weight loss, improved BP and lipids vs placebo/semaglutide. Safety consistent with triple-G class; global phase-2 and China phase-3 planned
24 March 2026
EU Innovation Fund commits €2.7bn to 54 net‑zero projects
Grant agreements signed; projects cover 17 countries and 17 sectors, set to avoid ~210 Mt CO2 in first 10 years. Six reserve projects invited (up to €491M). IF25 call open until 23 Apr 2026
24 March 2026
WuXi Biologics posts record 2025 results
2025 revenue +16.7% to RMB21.8bn; gross margin +500bps to 46%; EBITDA +38%; net profit +45%; 209 new integrated projects; backlog US$23.7bn; bi-/multi-specifics >120% growth
24 March 2026
UPM and Paramelt launch bio-based paper food packaging
Bio-based paper food-packaging with strong grease barrier at low coat weights. Recyclable and home-compostable. Runs on existing packaging lines; suited to bakery/fast-food
24 March 2026
MAIRE's Nextchem awarded two NX Replast™ feasibility studies for plastic upcycling in Southern Africa and Southeast Asia
Feasibility studies for two mechanical upcycling plants: ~25 KTPA in Southern Africa and 40 KTPA in Southeast Asia to convert polyolefin waste into high-quality compounded r-polymers
The right choices in the European chemical industry
Save time with
chemXplore Alpha
Learn more
24 March 2026
Sinopec Reports 2025 Results in Hong Kong
2025 results: revenue RMB2.78T; profit RMB32.476B; EPS RMB0.268; dividend RMB0.20/share. Oil/gas output rose; refining, chemicals and fuel sales grew; tech/digital advances.
23 March 2026
Roche opens Institute of Human Biology hub to accelerate drug discovery
IHB's new facility opens with space for 250 researchers to develop organoids, organ-on-chip and in silico human models to speed and de-risk drug discovery.
23 March 2026
Veolia to exit coal at Karviná by 2029 with multi‑energy plant
Transforms local heating to RDF/biomass/gas cogeneration (53% RDF), serving ~50,000 households, cutting CO2 by ~200,000 t, improving air quality and energy autonomy.
23 March 2026
Chugai obtains MHLW approval for Lunsumio–Polivy combo in relapsed/refractory large B‑cell lymphoma
Japan approves Lunsumio + Polivy for relapsed/refractory large B‑cell lymphoma after Phase III SUNMO: ORR 69.7%, PFS 11.5 vs 3.8 months (59% lower progression/death risk); manageable safety.
23 March 2026
Chugai: Roche discontinues GYM329 (emugrobart) development for SMA and FSHD
It showed safety and reduced mature myostatin but failed to deliver consistent functional benefits in SMA/FSHD trials; obesity studies will continue; no expected FY2026 earnings impact.
23 March 2026
Sinopec expands POE capacity with China's first full‑chain domestic IP
100kt solution‑method POE unit began linkage trials; with a 50kt demo and another 100kt under construction, domestic POE capacity reaches 250kt/yr. Metallocene catalyst + low‑VOC devolatilization enable varied grades for PV/EVs.
23 March 2026
GSK’s risvutatug rezetecan granted orphan drug designation for SCLC in Japan
Risvutatug rezetecan, a B7-H3–targeted ADC, showed durable responses in extensive‑stage SCLC in phase I ARTEMIS‑001; global phase III in relapsed ES‑SCLC is underway.
23 March 2026
KYORIN licenses novel drug candidates from UBE
Exclusive license grants development and commercialization rights with upfront, milestone and sales payments plus royalties. Partners will combine discovery compounds and R&D to accelerate treatments.
23 March 2026
Siemens expands industrial AI OS, unveils new tech and Alibaba Cloud partnership
Introduces 26 edge, automation and control products, cloud-enabled CAE, DC circuit breakers, AI cooling for data centers, upgraded PLCs, servo systems and predictive maintenance apps.
20 March 2026
Petrobras resumes investments in Minas Gerais during Lula visit
During Lula’s visit to Regap (Betim), resumption of investments announced: R$3.8bn (2026–30), up to R$9bn/10 yrs; 8k–36k jobs; +25k bpd capacity (2027) and 13.3 MW solar plant.
19 March 2026
EU invests €330m in fusion and nuclear R&D and skills
Work Programme funds fusion-to-grid R&D, a PPP, startups, skills and facilities; supports fission research on waste, safety, materials, medical isotopes and talent mobility.
19 March 2026
FDA approves Novo Nordisk’s Wegovy HD (7.2 mg) after ~21% weight loss in STEP UP trial
Higher‑dose semaglutide injection approved for adults with obesity after tolerating 2.4 mg; 31% reached ≥25% weight loss. Common AEs: GI symptoms and dysesthesia/altered skin sensation. Available April.
19 March 2026
Aptar’s Unidose Nasal Powder System Used in ENA Respiratory Phase II INNA‑051 Study
Powder nasal device used in a Phase II trial of a once-weekly spray to assess safety, tolerability and reduction of symptomatic infections; device offers single-dose precision and moisture protection.
19 March 2026
Novo Nordisk: FDA approves Wegovy HD (semaglutide 7.2 mg) — 20.7% mean weight loss
STEP UP: ~31% achieved ≥25% loss; STEP UP T2D mean loss 14.1%. FDA awarded National Priority Voucher. US launch expected April 2026. Safety/tolerability comparable to prior semaglutide doses.
19 March 2026
GSK: Lynavoy (linerixibat) FDA-approved for cholestatic pruritus in PBC
FDA approved linerixibat for cholestatic pruritus in adults with PBC after GLISTEN phase III showed rapid, sustained itch and sleep improvements. Common AEs: diarrhea, abdominal pain.
19 March 2026
Lilly's retatrutide lowers A1C up to 2% and weight up to 16.8% in Phase 3 T2D trial
Phase 3 TRANSCEND-T2D-1 met primary and key secondary endpoints at 40 weeks; weight loss continued without plateau. Common AEs: GI events; mild dysesthesia; improved lipids and systolic BP.
19 March 2026
Eni 2026–2030 Plan
Consistent strategy: strong E&P project pipeline driving 3-4% production growth to 2030, self-funding Transition units, CFFO rising to €17bn, €40-45bn FCF 2026-30, lower gearing and higher payouts.
19 March 2026
WACKER unveils BELNEXT bio-based ingredients at in-cosmetics Global 2026
TAL 1840 M: theanine-based cationic emulsifier (fermentation-made, biodegradable) for hair. EMO FH2: fermentation-made nonpolar emollient—stable, improves spread, combability and pigment dispersion
19 March 2026
Honeywell launches AI-powered Experion Operations Assistant
AI control-room tool Experion Operations Assistant uses historical and real-time data to forecast alarms (5-10 min ahead in pilots), integrates with Experion PKS and advises operators.
19 March 2026
BASF opens world's first industrial 3D‑printed catalyst plant in Ludwigshafen
X3D 3D-printed catalysts offer geometries that cut pressure drop, increase active surface and throughput, lower energy use; proven in customer plants.
19 March 2026
Plastic Energy powers start-up of TotalEnergies' Grandpuits advanced recycling plant
New 15,000 t/yr advanced recycling plant now producing TACOIL from hard-to-recycle plastics, feeding petrochemical sites to make high-quality, food- and medical-grade plastics.
19 March 2026
Asahi Kasei wins Tanahashi Prize for 10 MW alkaline electrolyzer durability
Pilot alkaline water electrolysis plants demonstrated long-term stable, multi-module operation, proving durability under variable renewables and enabling scale-up toward >100 MW systems
19 March 2026
Sinopec Wins Six Awards at 51st Geneva International Invention Exhibition
Two Jury Special Commendation Golds and four Golds; CO2-capture equipment also won a Special Innovation Award. Winners cover CO2 capture, heavy‑oil viscosity reduction, hydrogen and catalyst tech.
19 March 2026
Sinopec Completes Polymer Solid-State Battery Microgrid Demonstration
Polymer solid-state battery microgrid demo at Suzhou uses polymer solid electrolytes with TOPCon flexible and perovskite PV; upgraded storage and intelligent microgrid raised peak daily charging 47%
← Previous
Next →
